Pancreatic Cancer: Cause and Result of Diabetes Mellitus

Gastroenterology

Volumn 134, Issue 1, 2008, Pages 344-345

  Teich, Niels ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SURVIVAL; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; EDITORIAL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; IONIZATION; MYOBLAST; OBESITY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 37349024991     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.11.020     Document Type: Editorial

References (18)

1. Bright R. Cases and observations connected with disease of the pancreas and duodenum. Med Chir Tr 18 (1833) 1-56
2. Poel W.E., and Yergganian G. Adenocarcinoma of the pancreas in diabetes-prone Chinese hamsters. Am J Med 31 (1961) 861-863
3. Everhart J., and Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273 (1995) 1605-1609
4. Huxley R., Ansary-Moghaddam A., Berrington de Gonzalez A., et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92 (2005) 2076-2083
5. Stevens R.J., Roddam A.W., and Beral V. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer 96 (2007) 507-509
6. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 30 (2007) S42-S47
7. Chari S.T., Leibson C.L., Rabe K.G., et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134 (2008) 95-101
8. Basso D., Brigato L., Veronesi A., et al. The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res 15 (1995) 2585-2588
9. Fogar P., Pasquali C., Basso D., et al. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res 14 (1994) 2827-2830
10. Chari S.T., Leibson C.L., Rabe K.G., et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129 (2005) 504-511
11. Gupta S., Vittinghoff E., Bertenthal D., et al. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol 4 (2006) 1366-1372
12. Damiano J., Bordier L., Le Berre J.P., et al. Should pancreas imaging be recommended in patients over 50 years when diabetes is discovered because of acute symptoms?. Diabetes Metab 30 (2004) 203-207
13. Carpelan-Holmstrom M., Nordling S., Pukkala E., et al. Does anyone survive pancreatic ductal adenocarcinoma?. A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54 (2005) 385-387
14. Permert J., Larsson J., Westermark G.T., et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 330 (1994) 313
15. Basso D., Greco E., Fogar P., et al. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?. Clin Chim Acta 372 (2006) 120-128
16. Absetz P., Valve R., Oldenburg B., et al. Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial. Diabetes Care 30 (2007) 2465-2470
17. Dabelea D., Snell-Bergeon J.K., Hartsfield C.L., et al. Increasing prevalence of gestational diabetes mellitus (Gdiabetes mellitus) over time and by birth cohort: Kaiser Permanente of Colorado Diabetes Mellitus Screening Program. Diabetes Care 28 (2005) 579-584
18. Perrin M.C., Terry M.B., Kleinhaus K., et al. Gestational diabetes as a risk factor for pancreatic cancer: A prospective cohort study. BMC Med 5 (2007) 25